Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Investment of the day
    • Fitness startup...

    Fitness startup Mobiefit raises Rs 8.7 crore from NB Ventures and MediAssist India

    Written by Ruby Khatun Khatun Published On 2017-11-29T12:25:00+05:30  |  Updated On 29 Nov 2017 12:25 PM IST
    Fitness startup Mobiefit raises Rs 8.7 crore from NB Ventures and MediAssist India

    Health and Fitness startup Mobiefit has raised $1.35 million (Rs 8.7 crore) in a Pre-series A funding round led by NB Ventures and existing investor MediAssist India.


    This latest investment follows MobieFit’s seed round of $1 million in December 2015 by MediAssist and angel investors Siddharth Parekh, founder of private equity firm Paragon Partners, and SeedFund founder Mahesh Murthy.


    The startup is owned and operated by MobieFit Technologies Pvt. Ltd. The startup was established in 2015 by Gourav Jaswal, Shantanu Raghav, Pravar Peri and actress Gul Panag.


    The mobile fitness platform is supported by Prototyze, a startup incubator started which was started by Gourav Jaswal in October 2014. The incubator has also backed digital lending company Seynse, IoT transportation technology company TempoGO and SaaS platform HandyTrain, among others.


    The company operates two health-related products, MobieFit Run and MobieFit Body. MobieFit Run is a scientific program aimed at training beginners to run five km in nine weeks.


    MobieFit Body is a zero equipment exercise routine that requires just a few square feet of space and can be done in a hotel room, office, home, park or even gym. The program currently has more than 250 training videos in English, Hindi and other languages.


    “We have over 500,000 registered users, and more than 30,000 do fitness sessions at least monthly through a MobieFit app. Remarkably, three out of every 25 people who use the app for the first month, grow to do a staggering number of over 10 fitness sessions a month by the third month. This indicates a strong adherence and habituation” said Raghav, head of products at MobieFit.


    Gul Panag said, “With the launch of its paid programs six months ago, MobieFit became the first fitness app from India to offer training programs via in-app subscriptions”.


    Till now, the company’s app has crossed 750,000 downloads from its both products.


    NB Ventures, which led this funding round, is a Dubai-based capital firm with a $50 million startup fund. Its recent Indian investments include participation in $7 million series A funding for diet and nutrition company HealthifyMe.


    MediAssist is a healthcare data management company which claims to be processing insurance claims of over 25 million Indians and provides wellness services to over 5,500 companies.

    actress Gul PanagAngel Investorsfitnessfitness appGourav JaswalHandyTrainHealth Startuphealthcare SaaS platformInvestmentIoT transportation technologyMahesh MurthyMediAssist IndiaMobieFitMobieFit appMobieFit Technologies Pvt Ltdmobile fitness platformNB VenturesParagon PartnersPravar PeriPrototyzeRaisesSeedFundSeynseShantanu RaghavSiddharth ParekhstartupTempoGO
    Source : Press Release

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok